These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17289549)

  • 1. Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma.
    Zhang JY
    Autoimmun Rev; 2007 Jan; 6(3):143-8. PubMed ID: 17289549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
    Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
    J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
    Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.
    Hong Y; Long J; Li H; Chen S; Liu Q; Zhang B; He X; Wang Y; Li H; Li Y; Zhang T; Lu C; Yan H; Zhang M; Li Q; Cao B; Bai Z; Wang J; Zhang Z; Zhu S; Zheng J; Ou X; Ma H; Jia J; You H; Wang S; Huang J
    EBioMedicine; 2015 May; 2(5):438-46. PubMed ID: 26137588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
    Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
    World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
    Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
    Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.
    Zhang JY; Tan EM
    Expert Rev Mol Diagn; 2010 Apr; 10(3):321-8. PubMed ID: 20370589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
    Koziol JA; Imai H; Dai L; Zhang JY; Tan EM
    Cancer Immunol Immunother; 2018 May; 67(5):835-841. PubMed ID: 29497780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
    Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
    Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
    Liu M; Liu X; Ren P; Li J; Chai Y; Zheng SJ; Chen Y; Duan ZP; Li N; Zhang JY
    Tumour Biol; 2014 May; 35(5):4247-56. PubMed ID: 24390614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
    Chen Y; Zhou Y; Qiu S; Wang K; Liu S; Peng XX; Li J; Tan EM; Zhang JY
    Cancer Lett; 2010 Mar; 289(1):32-9. PubMed ID: 19683863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.
    Looi KS; Nakayasu ES; Diaz RA; Tan EM; Almeida IC; Zhang JY
    J Proteome Res; 2008 Sep; 7(9):4004-12. PubMed ID: 18672925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
    Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY
    Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
    Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
    Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers for hepatocellular carcinoma.
    Wu AH; Sell S
    Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
    Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM
    Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
    Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
    Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma.
    Wang K; Xu X; Nie Y; Dai L; Wang P; Zhang J
    Cancer Lett; 2009 Aug; 281(2):144-50. PubMed ID: 19304375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum autoantibody measurement for the detection of hepatocellular carcinoma.
    Middleton CH; Irving W; Robertson JF; Murray A; Parsy-Kowalska CB; Macdonald IK; McElveen J; Allen J; Healey GF; Thomson BJ; Ryder SJ; Holdenrieder S; Chapman CJ
    PLoS One; 2014; 9(8):e103867. PubMed ID: 25093332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
    Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
    Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.